← MHRA ALERTS
MHRA (UK) · MEDICINES RECALL/NOTIFICATION7 July 2026
UPDATE: Class 4 Medicines Defect Notification: Relonchem Limited, Gabapentin Relonchem 50mg/ml Oral Solution, EL(26)A/31
What this record is not
Alert details are published by the UK MHRA on GOV.UK; SPEQ surfaces them for reference and is not affiliated with or endorsed by the MHRA. The authoritative notice is on gov.uk.
Alert type
Medicines recall/notification
Alert date
7 July 2026
Regulator
MHRA (United Kingdom)
READ THE FULL ALERT
The complete MHRA alert — the affected products, batches, and the action required — is published on GOV.UK. SPEQ surfaces and indexes it for reference; the authoritative notice lives on gov.uk.
View on gov.uk →That is what MHRA published. A free account files it on your watchlist and sends one weekly email with whatever lands next.
Create a free account